The carrier screening market is expected to grow at a strong CAGR of 13.3% due to continued technological advancements in carrier testing and growing consumer interest in personalized medicines.
Selbyville, Delaware, June 11, 2023 (Globe Newswire) —
The career screening market is projected to reach US$6 billion by 2032. Growing demand for personalized medicine will be a major factor driving industry trends. Carrier screening provides individualized information about an individual’s genetic risk and works with customizable medicines by understanding carrier status. Information from these tests helps individuals make informed decisions about family planning, reproductive options, and prenatal care.
Request a sample of this research report@ https://www.gminsights.com/request-sample/detail/5759
Awareness of Preconception Testing to Facilitate Targeted Disease Screening Segments
The industry is divided into targeted disease carrier screening and extended carrier screening. The targeted disease carrier screening market segment share is expected to rise significantly by 2032. Increased awareness among individuals and couples about the importance of preconception testing is driving product adoption. Carrier screening helps identify genetic variants that may be passed on to children, allowing couples to make more informed reproductive decisions. Additionally, increasing competition among testing agencies and companies has increased the accessibility, affordability, and availability of carrier screening services.
Reference lab to gain considerable popularity
The carrier screening industry is segmented into hospitals, clinics and clinics, reference laboratories, and others. The reference laboratory sector is expected to show a significant CAGR by 2032 due to the rising prevalence of genetic diseases. Carrier screening helps individuals identify carrier status for various genetic disorders, allowing them to assess their risk of passing on these disorders to their children. Reference laboratories are making a significant contribution to the market as more people seek carrier screening.
Browse 190 pages of key industry insights, including the report’s 411 market data tables and 17 figures and charts.“Carrier Screening Market Size (By Type (Extended Carrier Screening, Targeted Disease Screening)), By Technology (DNA Sequencing, PCR), By Medical Condition (Pulmonary Disease, Neurological Disease), By End Use (Hospital) , and forecast ”, 2023–2032” Detailed explanation with table of contents
https://www.gminsights.com/industry-analysis/carrier-screening-market
Establishing a medical infrastructure that drives European industry
The European market is expected to be lucrative by 2032 due to the well-established medical infrastructure with access to advanced genetic testing laboratories and specialty clinics in the region. The availability of skilled medical professionals, including genetic counselors and specialists, supports the expansion of the carrier screening industry by providing accurate and comprehensive screening services. In addition, government support and funding aimed at identifying carriers of genetic diseases and providing individuals with counseling and reproductive options are driving the growth of local industries.
Secure a copy of the premium research report @ https://www.gminsights.com/securecheckout/paymenta/5759?gmpaycod=sugmp
Leading Career Screening Market Players
Top players profiled in the career screening industry report include Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Fulgent Genetics Inc., BGI Genomics, Quest Diagnostics Inc., InVitae Corporation, and Illumina Inc. will be
Career Screening Market News
-
In April 2023, scientific instrument supplier Thermo Fisher Scientific entered into a deployment agency agreement with genetic testing solutions provider Devyser to commercialize Devyser’s post-transplant NGS product portfolio. The company will provide carrier screening technology to further promote its products in North America and Europe.
-
In September 2023, Quest Diagnostics Inc. partnered with Lee Health to improve the quality of diagnostic services and improve patient and physician comfort. This will allow the company to provide laboratory expertise for genetic research.
Part of the table of contents (ToC) of the report:
Chapter 3 Career Screening Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry influence
3.2.1 Drivers of growth
3.2.1.1 Raising Awareness Combined with Emphasis on Early Diagnosis of Genetic Diseases
3.2.1.2 Rapidly increasing in vitro fertilization and introduction of cryopreservation
3.2.1.3 Technological advances in carrier screening
3.2.1.4 Growing consumer interest in personalized medicine
3.2.2 Industry pitfalls and challenges
3.2.2.1 High Cost and Reimbursement Issues for Carrier Testing
3.2.2.2 Lack of standard guidelines and skilled professionals
3.3 Analysis of growth potential
3.3.1 By type
3.3.2 By Technology
3.3.3 By medical condition
3.3.4 By End Use
3.4 Impact Analysis of COVID-19
3.5 Regulatory landscape
3.5.1 United States
3.5.2 Europe
3.6 Future Market Trends
3.7 Marketing strategy analysis
3.8 Technology Perspective
3.9 Redemption Scenario
3.10 Policy outlook
3.11 Gap analysis
3.12 Porter’s analysis
3.13 Pestel Analysis
Chapter 4 Competitive Landscape in 2022
4.1 Introduction
4.2 Company Matrix Analysis, 2022
4.3 Competitive Positioning Matrix
4.4 Vendor Matrix Analysis
4.5 Strategic Dashboard, 2022
Browse Report Store – GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Headquartered in Delaware, USA, Global Market Insights Inc. is a global market research and consulting services provider, providing growth consulting services as well as syndicated and custom research reports. Our business intelligence and industry research reports provide clients with insights and actionable market data specifically designed and presented to aid strategic decision making. These exhaustive reports are designed with a unique research methodology and are available across key industries including chemical, advanced materials, technology, renewable energy and biotechnology.
CONTACT: Contact Us: Aashit Tiwari Corporate Sales, USA Global Market Insights Inc. Toll Free: +1-888-689-0688 USA: +1-302-846-7766 Europe: +44-742-759-8484 APAC: +65-3129-7718 Email: sales@gminsights.com Read More News @ https://ibmag.com
